Akari Therapeutics, Plc Current Assets
Akari Therapeutics, Plc (AKTX) had Current Assets of $8.32 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $8.32M.
- 2026-03-31: Assets, Current $3.59M.
- 2025-12-31: Assets, Current $5.46M.
- 2025-09-30: Assets, Current $2.95M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.32M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.59M 10-Q · filed 2026-05-19 | |
| 2025-12-31 | $5.46M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.95M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.30M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $3.35M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.95M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.73M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $1.33M 8-K · filed 2024-09-06 | $5.08M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $2.77M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.34M 10-K · filed 2025-04-15 | |
| 2023-06-30 | $8.00M 6-K · filed 2023-09-29 | |
| 2022-12-31 | $3.23M 8-K · filed 2024-09-06 | $13.81M 20-F · filed 2023-05-01 |
| 2022-06-30 | $11.35M 6-K · filed 2022-09-27 | |
| 2021-12-31 | $11.63M 20-F · filed 2023-05-01 | |
| 2021-06-30 | $4.80M 6-K · filed 2021-09-22 | |
| 2020-12-31 | $14.58M 20-F · filed 2022-05-16 | |
| 2020-09-30 | $13.67M 20-F · filed 2021-04-21 | |
| 2020-06-30 | $14.43M 20-F · filed 2021-04-21 | |
| 2020-03-31 | $9.65M 20-F · filed 2021-04-21 | |
| 2019-12-31 | $6.44M 20-F · filed 2021-04-21 | $6.77M 20-F · filed 2020-03-31 |
| 2019-09-30 | $10.23M 20-F · filed 2021-04-21 | |
| 2019-06-30 | $4.55M 20-F · filed 2021-04-21 | $5.09M 6-K · filed 2019-08-29 |
| 2019-03-31 | $8.03M 20-F · filed 2021-04-21 | |
| 2018-12-31 | $7.45M 20-F · filed 2020-03-31 | |
| 2018-06-30 | $16.52M 6-K · filed 2018-09-27 | |
| 2017-12-31 | $28.81M 20-F · filed 2019-04-23 | |
| 2017-06-30 | $31.81M 6-K · filed 2017-08-10 | |
| 2016-12-31 | $45.63M 20-F · filed 2018-07-18 | |
| 2016-06-30 | $57.37M 6-K · filed 2017-04-14 | |
| 2016-03-31 | $62.69M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $69.66M 6-K · filed 2017-04-14 | |
| 2015-09-30 | $78.94M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $2.92M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $4.27M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $3.34M 10-K · filed 2016-03-23 | $6.43M 10-K · filed 2015-02-11 |
| 2013-12-31 | $7.83M 10-K · filed 2015-02-11 | |
| 2012-12-31 | $1.12M 20-F · filed 2014-03-24 | |
| 2011-12-31 | $27.00K 20-F/A · filed 2013-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |